[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Controversies
July 8, 1998

Update on FDA Regulation of In Vitro Diagnostic Devices

Author Affiliations

From the Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Md.

 

Controversies section editor: Phil B. Fontanarosa, MD, Senior Editor.

JAMA. 1998;280(2):190-192. doi:10.1001/jama.280.2.190

THE FOOD AND Drug Administration's (FDA's) authority for regulation of laboratory tests (in vitro diagnostic devices or IVDs) was established as a result of passage of the Medical Device Amendments of 1976.1 Under this law, all medical devices (including IVDs) are subject to a variety of controls, including the requirement for manufacturers to register with the FDA and list their products, to comply with Current Good Manufacturing Practice, and to report serious device failures. This law provided the agency, for the first time in the late 1970s, with an inventory of tests already in the marketplace, tools to require that manufacturing practices be sound, and a system to ensure that serious problems are identified and remedied. In addition, the law put into place requirements for premarket review of medical devices entering the market for the first time.

First Page Preview View Large
First page PDF preview
First page PDF preview
×